Adcetris (Brentuximab Vedotin)

Overview
Adcetris is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat several types of lymphoma, including classical Hodgkin lymphoma (cHL), systemic anaplastic large cell lymphoma…

Arranon (Nelarabine)

Overview
Arranon is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia. Arranon is indicated in cases where… read more

Beleodaq (Belinostat)

Overview
Beleodaq is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat peripheral T-cell lymphoma that has relapsed or failed to respond to other drugs. Beleodaq is also referred… read more

Bendeka (Bendamustine Hydrochloride)

Overview
Bendeka is approved by the U.S. Food and Drug Administration (FDA) for the treatment of indolent B-cell non-Hodgkin lymphoma (NHL) in people whose disease has progressed during or within six months of treatment…

BiCNU (Carmustine)

Overview
BiCNU, also known by its drug name, carmustine, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma… read more

Boruzu (Bortezomib)

Overview
Boruzu is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with mantle cell lymphoma, a type of non-Hodgkin lymphoma that affects the lymphatic system. Boruzu is also known by…

Breyanzi (Lisocabtagene Maraleucel)

Overview
Breyanzi is approved by the U.S. Food and Drug Administration (FDA) for the treatment of several types of relapsed or refractory lymphoma, including large B-cell lymphoma (LBCL), chronic lymphocytic leukemia…

Brukinsa (Zanubrutinib)

Overview
Brukinsa is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL); Waldenström’s macroglobulinemia…

Calquence (Acalabrutinib) for Lymphoma

Overview
Calquence is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with mantle cell lymphoma (MCL), a type of lymphoma (cancer that begins in the lymphatic system). Calquence may be…

Columvi (Glofitamab-Gxbm)

Overview
Columvi is approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBLC) not otherwise specified or large B-cell lymphoma (LBCL) arising…

Copiktra (Duvelisib)

Overview
Copiktra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat non-Hodgkin lymphomas including small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL), and… read more

Epkinly (Epcoritamab-bysp)

Overview
Epkinly is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, in adults who have already… read more

Folotyn (Pralatrexate)

Overview
Folotyn is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat peripheral T-cell lymphoma (PTCL) that has relapsed or failed to respond to other drugs. Folotyn is also… read more

Gazyva (Obinutuzumab)

Overview
Gazyva is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat follicular lymphoma and chronic lymphocytic leukemia. Gazyva is often prescribed in combination with other drugs… read more

Gleostine (Lomustine)

Overview
Gleostine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat Hodgkin lymphoma that has progressed after initial therapy. Gleostine is often combined with a chemotherapy… read more

Imbruvica (Ibrutinib)

Overview
Imbruvica is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat several types of non-Hodgkin lymphoma, including mantle cell lymphoma, chronic lymphocytic leukemia (CLL)/small… read more

Istodax (Romidepsin)

Overview
Istodax is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat cutaneous T-cell lymphoma and peripheral T-cell lymphoma (PTCL). Istodax is indicated in cases where at least… read more

Jaypirca (Pirtobrutinib))

Overview
Jaypirca is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)… read more

Keytruda (Pembrolizumab)

Overview
Keytruda is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cancers including classic Hodgkin lymphoma and primary mediastinal B-cell lymphoma. Keytruda is indicated in cases… read more

Kymriah (Tisagenlecleucel)

Overview
Kymriah is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with large B-cell lymphoma. Kymriah is indicated when lymphoma is relapsed or refractory and at least two… read more

Leukeran (Chlorambucil)

Overview
Leukeran is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), lymphosarcoma, and giant follicular lymphoma. Leukeran… read more

Lunsumio (Mosunetuzumab-axgb)

Overview
Lunsumio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory follicular lymphoma who have already tried two types of systemic therapy… read more

Lymphir (Denileukin Diftitox-Cxdl)

Overview
Lymphir is a biologic treatment approved by the U.S. Food and Drug Administration (FDA) for adults with relapsed or refractory stage 1 through stage 3 cutaneous T-cell lymphoma who have already received at least…

Matulane (Procarbazine)

Overview
Matulane is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat stage III and stage IV Hodgkin lymphoma. Matulane is part of the MOPP chemotherapy regimen in combination… read more

Monjuvi (Tafasitamab-Cxix)

Overview
Monjuvi is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with two types of relapsed or refractory (returned or not responding to treatment) lymphoma. It is used in…

Neulasta (Pegfilgrastim)

Overview
Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections after receiving chemotherapy or some types of radiation. Neulasta is also known by… read more

Opdivo (Nivolumab)

Overview
Opdivo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cancers including classic Hodgkin lymphoma. Opdivo is indicated in cases where lymphoma has relapsed or progressed… read more

Polivy (Polatuzumab Vedotin-Piiq) for Lymphoma

Overview

Polivy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain types of large B-cell lymphoma. It is indicated in combination with a rituximab product, cyclophosphamide…

Poteligeo (Mogamulizumab-kpkc)

Overview
Poteligeo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory mycosis fungoides (MF) and adults with relapsed or refractory Sézary syndrome… read more

Revlimid (Lenalidomide)

Overview
Revlimid is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat mantle cell lymphoma and multiple myeloma. Revlimid is often combined with other drugs such as a… read more

Riabni (Rituximab-Arrx)

Overview
Riabni (rituximab-arrx) is a U.S. Food and Drug Administration (FDA)-approved treatment for adults with non-Hodgkin’s lymphoma (NHL), a type of cancer that affects the lymphatic system (part of the immune system…

Rituxan (Rituximab)

Overview
Rituxan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat non-Hodgkin lymphoma. Rituxan may be prescribed alone or in combination with other antilymphoma drugs. Rituxan may… read more

Rituxan Hycela (Rituximab/hyaluronidase human)

Overview
Rituxan Hycela is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat follicular lymphoma, diffuse large B-cell lymphoma (DLBCL), and chronic lymphocytic leukemia (CLL). Rituxan… read more

Ruxience (Rituximab-Pvvr)

Overview
Ruxience (rituximab-pvvr) is a U.S. Food and Drug Administration (FDA)-approved treatment for adults with non-Hodgkin’s lymphoma (NHL), a type of cancer that starts in the lymphatic system (part of the immune…

Tecartus (Brexucabtagene autoleucel)

Overview
Tecartus is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory mantle cell lymphoma (MCL) in adults. Tecartus is only available through a… read more

Treanda (Bendamustine)

Overview
Treanda is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma. Treanda is sometimes prescribed as… read more

Truxima (Rituximab-Abbs)

Overview
Truxima (rituximab-abbs) is a U.S. Food and Drug Administration (FDA)-approved treatment for adults with non-Hodgkin’s lymphoma (NHL), a type of cancer that starts in the lymphatic system (part of the immune…

Velcade (Bortezomib)

Overview
Velcade, also known by its drug name bortezomib, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat mantle cell lymphoma and multiple myeloma. Velcade is often combined… read more

Venclexta (Venetoclax)

Overview
Venclexta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and adults over 75 years old… read more

Vinblastine

Overview

Vinblastine is a prescription medication used to treat several types of cancer including Hodgkin lymphoma (stages 3 and 4), lymphocytic lymphoma, histiocytic lymphoma, and mycosis fungoides. Vinblastine is often…

Xalkori (Crizotinib)

Overview
Xalkori is approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers that are positive for anaplastic lymphoma kinase (ALK) or ROS1. Among its specific indications, it’s approved for…

Yescarta (Axicabtagene ciloleucel)

Overview
Yescarta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with large B-cell lymphoma. Yescarta is indicated when lymphoma is relapsed or refractory and at least two… read more

Zevalin (Ibritumomab tiuxetan)

Overview
Zevalin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat non-Hodgkin lymphoma (NHL). Specifically, Zevalin is indicated for use in low-grade or follicular B-cell lymphoma… read more

Zolinza (Vorinostat)

Overview
Zolinza is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat skin symptoms in people with cutaneous T-cell lymphoma (CTCL). Zolinza is indicated for use in patients when… read more

Zydelig (Idelalisib)

Overview
Zydelig is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed cases of follicular B-cell non-Hodgkin lymphoma, small lymphocytic lymphoma (SLL), and chronic lymphocytic… read more

Zynlonta (Loncastuximab Tesirine-Lpyl)

Overview
Zynlonta is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. This includes…